DNLI has been granted a new patent
Jan 29, 2025, 11:38 PM
-20.55%
What does DNLI do
Denali Therapeutics, a biopharmaceutical company based in South San Francisco, develops therapies for neurodegenerative diseases, with seven clinical candidates and ongoing studies for conditions like ALS and Parkinson's disease. The company went public on December 8, 2017, and has 375 employees.
DNLI filed a patent for "anti-her2 antibodies and methods of use thereof" on Thu, February 22, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.